Allarity Therapeutics Inc (ALLR) — Cash Flow-to-Debt Ratio
Allarity Therapeutics Inc (ALLR) has a Cash Flow-to-Debt Ratio of -0.38x as of December 2025, meaning its operating cash flow of $-3.24 Million could theoretically repay 0% of its total liabilities ($8.43 Million) in one year. See ALLR cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Allarity Therapeutics Inc Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Allarity Therapeutics Inc across 11 annual periods. Also explore ALLR year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Allarity Therapeutics Inc (2015–2025)
Year-by-year debt coverage analysis for Allarity Therapeutics Inc. For market capitalisation and broader financial context, see market value of Allarity Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.76x | $-14.82 Million | $8.43 Million | ▼ -9.8% |
| 2024 | -1.60x | $-17.35 Million | $10.84 Million | ▼ -83.6% |
| 2023 | -0.87x | $-12.74 Million | $14.61 Million | ▲ +34.4% |
| 2022 | -1.33x | $-16.82 Million | $12.65 Million | ▼ -172.4% |
| 2021 | -0.49x | $-15.05 Million | $30.85 Million | ▲ +55.9% |
| 2020 | -1.11x | $-7.25 Million | $6.55 Million | ▼ -17.1% |
| 2019 | -0.94x | $-10.11 Million | $10.70 Million | ▼ -138.2% |
| 2018 | -0.40x | $-4.24 Million | $10.69 Million | ▲ +49.9% |
| 2017 | -0.79x | $-1.34 Million | $1.70 Million | ▲ +73.4% |
| 2016 | -2.98x | $-3.98 Million | $1.34 Million | ▲ +24.0% |
| 2015 | -3.92x | $-2.03 Million | $518.15K | — |